BCL2 and prostate carcinoma: For instance, RU486 may induce apoptosis in LNCaP prostate cancer line with a mechanism not antagonized by progesterone or hydrocortisone; conversely, an additive effect of the combination of RU486 with the two steroids on the increase in DNA fragmentation and Bcl2 downregulation was observed (13).